ActiGraph Revenue and Competitors
Estimated Revenue & Valuation
- ActiGraph's estimated annual revenue is currently $34.6M per year.
- ActiGraph's estimated revenue per employee is $251,000
Employee Data
- ActiGraph has 138 Employees.
- ActiGraph grew their employee count by 9% last year.
ActiGraph's People
Name | Title | Email/Phone |
---|---|---|
1 | Software Engineer II | Reveal Email/Phone |
2 | Sales Operations Specialist | Reveal Email/Phone |
ActiGraph Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $238.8M | 1193 | -5% | $66M | $2.1B |
What Is ActiGraph?
ActiGraph is the leading provider of medical-grade physical activity and sleep monitoring solutions for the global scientific community. ActiGraph's wearable actigraphy monitors and robust analytics platform have been widely used to quantify human movement in academic and population health research for nearly two decades. In recent years, the company's monitoring solutions have been steadily adopted by biopharma and life sciences organizations seeking to capture real-world objective outcomes related to physical activity, mobility, and sleep behavior for patients enrolled in clinical trials.
keywords:Healthcare,Medical Devices,Medical Diagnostics,PharmaceuticalsN/A
Total Funding
138
Number of Employees
$34.6M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ActiGraph News
Actigraphy Sensors Market Size, Share, Growth 2022-2029| Key Players Activinsights, Philips Respironics, Aetna, · The research study on the...
Some of the Major Key players profiled in the study are ActiGraph, LLC., BMC Medical Co., Ltd, Braebon Medical Corporation,...
ActiGraph further solidifies its reputation as an innovator in clinical trials by joining an organization aimed to make research...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.4M | 138 | 9% | N/A |
#2 | $17.3M | 157 | 7% | N/A |
#3 | $56.5M | 159 | 13% | N/A |
#4 | $37M | 160 | 3% | N/A |
#5 | $58.6M | 165 | 9% | N/A |